Xeris Biopharma Holdings, Inc. (XERS)
Market Closed
17 Jul, 20:00
$
8. 80
+0.11
+1.2658%
$
1.43B Market Cap
- P/E Ratio
- Div Yield
1.61M Volume
-0.38 Eps
$ 8.69
Previous Close 
Want to track XERS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xeris Biopharma Holdings, Inc. (XERS) Statistics
Valuation metrics
Market Cap 1.43B
Enterprise value 1.44B
Trailing P/E (ttm) 124.29
Forward P/E 15.85
PEG ratio 0.01
Price/Sales (ttm) 4.83
Price/Book (mrq) 115.33
Enterprise Value/Revenue 4.59
Enterprise Value/EBITDA 31.32
Overview
Shares outstanding 172.56M
Float 163.84M
Shares short 15.89M
% Held by insiders 0.03%
% Held by institutions 0.62%
Average volume (10 days) 1.4M
Average volume (90 days) 1.84M
Price summary
52-Week low 4.87
52-Week high 10.08
Beta 0.92
50-Day moving average 7.32
200-Day moving average 6.52
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.04%
Operating margin 0.11%
Operational effectiveness
Return on assets 0.03%
Return on equity 7.35%
Income Statement
Revenue (ttm) 314.85M
Revenue per share (ttm) 1.85
Quarterly revenue growth (yoy) 0.38%
Gross profit (ttm) 270.44M
EBITDA 53.43M
Net income to common (ttm) 12.01M
Diluted EPS (ttm) 0.07
Quarterly earnings growth (yoy) 0.38%
Balance Sheet
Total cash (mrq) 111.75M
Total cash per share (mrq) 0.66
Total debt (mrq) 258.55M
Total Debt/Equity (mrq) 2.87
Current ratio (mrq) 2.12%
Book value per share (mrq) 0.08
Cash Flow
Cash flow statement 48.53M
Levered free cash flow (LFCF) 42.21M
